CDC

CDC recommends second COVID-19 vaccine dose for seniors and immunocompromised

October 25, 2024

CDC recommends the second dose of 2024-2025 COVID-19 vaccine be administered six months after the first dose. The goal is to enhance protection against severe COVID-19 outcomes, particularly for those at higher risk, and to provide clear guidance on vaccination schedules for health care providers. This update also allows for additional doses based on clinical decisions.

Source:

CDC. (2024, October 23). CDC Recommends Second Dose of 2024-2025 COVID-19 Vaccine for People 65 Years and Older and for People Who are Moderately or Severely Immunocompromised. https://www.cdc.gov/media/releases/2024/s1023-covid-19-vaccine.html